Sorafenib News and Research

RSS
Sorafenib (Nexavar) is an oral multikinase inhibitor for the treatment of two common types of cancer, hepatocellular carcinoma (HCC) and advanced renal cell carcinoma (RCC).
New nanoplatform technology may reverse drug-resistance in renal cell carcinoma

New nanoplatform technology may reverse drug-resistance in renal cell carcinoma

China NMPA approves LENVIMA for treatment of unresectable hepatocellular carcinoma

China NMPA approves LENVIMA for treatment of unresectable hepatocellular carcinoma

CHMP provides positive opinion to Cabometyx for previously-treated patients with hepatocellular carcinoma

CHMP provides positive opinion to Cabometyx for previously-treated patients with hepatocellular carcinoma

NCCN updates Clinical Practice Guidelines to include new recommendations for CABOMETYX tablets

NCCN updates Clinical Practice Guidelines to include new recommendations for CABOMETYX tablets

Eisai: EC approves marketing of LENVIMA as first-line treatment for hepatocellular carcinoma

Eisai: EC approves marketing of LENVIMA as first-line treatment for hepatocellular carcinoma

Scientists develop novel peptide drug that could potentially stop development of liver cancer

Scientists develop novel peptide drug that could potentially stop development of liver cancer

U.S. researchers recommend development of anti-cancer drugs based on mechanism of Namodenoson

U.S. researchers recommend development of anti-cancer drugs based on mechanism of Namodenoson

Can-Fite provides update on Phase II clinical trial with drug candidate Namodenoson

Can-Fite provides update on Phase II clinical trial with drug candidate Namodenoson

Opdivo plus low-dose Yervoy shows promising results in treating renal cell carcinoma patients

Opdivo plus low-dose Yervoy shows promising results in treating renal cell carcinoma patients

Study confirms no survival benefit of adding SIRT to standard treatment for liver cancer

Study confirms no survival benefit of adding SIRT to standard treatment for liver cancer

Scientists find new way to kill liver cancer cells

Scientists find new way to kill liver cancer cells

New organ-on-a-chip technology provides simple setting to study blood vessel formation

New organ-on-a-chip technology provides simple setting to study blood vessel formation

Researchers use gold nanoshells to effectively release cancer drugs inside tumors

Researchers use gold nanoshells to effectively release cancer drugs inside tumors

Reduced dose of chemotherapy has no effect on overall survival of liver cancer patients

Reduced dose of chemotherapy has no effect on overall survival of liver cancer patients

Stivarga receives expanded FDA approval for treatment of liver cancer

Stivarga receives expanded FDA approval for treatment of liver cancer

Study reveals promising results for primary liver cancer patients treated with SIR-Spheres Y-90 resin microspheres

Study reveals promising results for primary liver cancer patients treated with SIR-Spheres Y-90 resin microspheres

Study provides insight into how microRNA may amplify effects of drug treatment in liver cancer

Study provides insight into how microRNA may amplify effects of drug treatment in liver cancer

New computational tool can predict personal cancer driver genes to optimize treatment

New computational tool can predict personal cancer driver genes to optimize treatment

Scientists unravel novel role of signalling protein in common type of liver cancer

Scientists unravel novel role of signalling protein in common type of liver cancer

Researchers to explore potential roles of tumor-suppressor gene in kidney cancer

Researchers to explore potential roles of tumor-suppressor gene in kidney cancer